Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China
· Delayed Price · Currency is CNY 35.32
+1.39 (4.10%)
Mar 10, 2026, 11:15 AM CST
SHA:688062 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -1,044 | -1,053 | -955.23 | -769.59 | Upgrade
|
| Depreciation & Amortization | - | 129.21 | 104.31 | 89.29 | 80.46 | Upgrade
|
| Other Amortization | - | 17.01 | 5.14 | 6.58 | 6.82 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0 | -0.33 | -2.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.11 | 3.56 | 0.02 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 4.07 | 1.25 | -1.8 | -3.85 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.03 | 0.03 | -0.01 | -0.03 | Upgrade
|
| Other Operating Activities | - | 56.42 | 16.76 | 9.07 | 2.48 | Upgrade
|
| Change in Accounts Receivable | - | -77.36 | -42.88 | 15.21 | -24.01 | Upgrade
|
| Change in Inventory | - | -57.91 | -86.18 | -40.88 | -7.73 | Upgrade
|
| Change in Accounts Payable | - | -36.24 | 149.89 | 6.57 | 109.33 | Upgrade
|
| Change in Other Net Operating Assets | - | 28.82 | 118.2 | 152.33 | 185.77 | Upgrade
|
| Operating Cash Flow | - | -956.44 | -782.73 | -719.17 | -422.4 | Upgrade
|
| Capital Expenditures | - | -330.07 | -499.91 | -544.96 | -217.51 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0 | 0.01 | - | Upgrade
|
| Cash Acquisitions | - | - | -24 | - | - | Upgrade
|
| Investment in Securities | - | 35.53 | 11.72 | -60 | 225.41 | Upgrade
|
| Other Investing Activities | - | 2.99 | 2.57 | 2.15 | 4.94 | Upgrade
|
| Investing Cash Flow | - | -291.55 | -509.62 | -602.8 | 12.84 | Upgrade
|
| Long-Term Debt Issued | - | 3,605 | 605.3 | 460.07 | 142.87 | Upgrade
|
| Total Debt Issued | - | 3,605 | 605.3 | 460.07 | 142.87 | Upgrade
|
| Long-Term Debt Repaid | - | -2,705 | -133.06 | -37.91 | -69.09 | Upgrade
|
| Total Debt Repaid | - | -2,705 | -133.06 | -37.91 | -69.09 | Upgrade
|
| Net Debt Issued (Repaid) | - | 900.38 | 472.23 | 422.17 | 73.78 | Upgrade
|
| Issuance of Common Stock | - | - | - | 3,323 | 125.95 | Upgrade
|
| Common Dividends Paid | - | -66.11 | -34.1 | -13.12 | -0.79 | Upgrade
|
| Other Financing Activities | - | -2.57 | 6.8 | -16.1 | - | Upgrade
|
| Financing Cash Flow | - | 831.7 | 444.94 | 3,716 | 198.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.23 | 1.4 | 2.26 | -1.01 | Upgrade
|
| Net Cash Flow | - | -416.07 | -846.01 | 2,396 | -211.63 | Upgrade
|
| Free Cash Flow | - | -1,287 | -1,283 | -1,264 | -639.91 | Upgrade
|
| Free Cash Flow Margin | - | -643.96% | -1003.35% | -4559.01% | -3943.69% | Upgrade
|
| Free Cash Flow Per Share | - | -3.22 | -3.21 | -3.23 | -2.14 | Upgrade
|
| Cash Income Tax Paid | - | 20.98 | -69.09 | -141.94 | 0.99 | Upgrade
|
| Levered Free Cash Flow | - | -1,063 | -824.71 | -925.61 | -354.48 | Upgrade
|
| Unlevered Free Cash Flow | - | -1,027 | -816.37 | -919.18 | -350.47 | Upgrade
|
| Change in Working Capital | - | -119.37 | 139.65 | 133.23 | 263.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.